Neglected but important role of apolipoprotein E exchange in hepatitis C virus infection

Journal of Virology

Volumn 90, Issue 21, 2016, Pages 9632-9643

  Yang, Zaili ^a,b   Wang, Xiaoning ^a   Chi, Xiumei ^c   Zhao, Fanfan ^a   Guo, Jinxu ^a   Ma, Pengjuan ^a   Zhong, Jin ^a   Niu, Junqi ^c   Pan, Xiaoyu ^a   Long, Gang ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b SHANGHAI UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL ADHESION; CELL FRACTIONATION; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; WESTERN BLOTTING; HEPACIVIRUS; HEPATITIS C; METABOLISM; PHYSIOLOGY; VIROLOGY;

APOLIPOPROTEINS E; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; LIPOPROTEINS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 84994045380     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01353-16     Document Type: Article

References (44)

1. Yamane D, McGivern DR, Masaki T, Lemon SM. 2013. Liver injury and disease pathogenesis in chronic hepatitis C. Curr Top Microbiol Immunol 369:263-288.
2. Larrat S, Vallet S, David-Tchouda S, Caporossi A, Margier J, Ramiere C, Scholtes C, Haim-Boukobza S, Roque-Afonso AM, Besse B, Andre-Garnier E, Mohamed S, Halfon P, Pivert A, LeGuillou-Guillemette H, Abravanel F, Guivarch M, Mackiewicz V, Lada O, Mourez T, Plantier JC, Baazia Y, Alain S, Hantz S, Thibault V, Gaudy-Graffin C, Bouvet D, Mirand A, Henquell C, Gozlan J, Lagathu G, Pronier C, Velay A, Schvoerer E, Trimoulet P, Fleury H, Bouvier-Alias M, Brochot E, Duverlie G, Maylin S, Gouriou S, Pawlotsky JM, Morand P. 2015. Naturally occurring resistance-associated variants of hepatitisCvirus protease inhibitors in poor responders to pegylated interferon-ribavirin. J Clin Microbiol 53:2195-2202. http://dx.doi.org/10.1128/JCM.03633-14.
3. Pawlotsky JM. 2014. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 146:1176-1192. http://dx.doi.org/10.1053/j.gastro.2014.03.003.
4. Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH. 2015. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol 62:S87-S99. http://dx.doi.org/10.1016/j.jhep.2015.02.006.
5. André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Brechot C, Paranhos-Baccala G, Lotteau V. 2002. Characterization of low-and very-low-density hepatitis C virus RNAcontaining particles. J Virol 76:6919-6928. http://dx.doi.org/10.1128/JVI.76.14.6919-6928.2002.
6. Calattini S, Fusil F, Mancip J, Dao Thi VL, Granier C, Gadot N, Scoazec JY, Zeisel MB, Baumert TF, Lavillette D, Dreux M, Cosset FL. 2015. Functional and biochemical characterization of hepatitis C virus (HCV) particles produced in a humanized liver mouse model. J Biol Chem 290: 23173-23187. http://dx.doi.org/10.1074/jbc.M115.662999.
7. Fukuhara T, Ono C, Puig-Basagoiti F, Matsuura Y. 2015. Roles of lipoproteins and apolipoproteins in particle formation of hepatitis C virus. Trends Microbiol 23:618-629. http://dx.doi.org/10.1016/j.tim.2015.07.007.
8. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Jr, Ye J. 2007. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104:5848-5853. http://dx.doi.org/10.1073/pnas.0700760104.
9. Lindenbach BD, Rice CM. 2013. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11:688-700. http://dx.doi.org/10.1038/nrmicro3098.
10. Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. 2006. Association between hepatitis C virus and verylow-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80:2418-2428. http://dx.doi.org/10.1128/JVI.80.5.2418-2428.2006.
11. Nielsen SU, Bassendine MF, Martin C, Lowther D, Purcell PJ, King BJ, Neely D, Toms GL. 2008. Characterization of hepatitis C RNAcontaining particles from human liver by density and size. J Gen Virol 89:2507-2517. http://dx.doi.org/10.1099/vir.0.2008/000083-0.
12. Paul D, Madan V, Bartenschlager R. 2014. Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host Microbe 16:569-579. http://dx.doi.org/10.1016/j.chom.2014.10.008.
13. Boyer A, Dumans A, Beaumont E, Etienne L, Roingeard P, Meunier JC. 2014. The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles. J Biol Chem 289:18904-18913. http://dx.doi.org/10.1074/jbc.M113.538256.
14. Catanese MT, Uryu K, Kopp M, Edwards TJ, Andrus L, Rice WJ, Silvestry M, Kuhn RJ, Rice CM. 2013. Ultrastructural analysis of hepatitis C virus particles. Proc Natl Acad Sci U S A 110:9505-9510. http://dx.doi.org/10.1073/pnas.1307527110.
15. Dubuisson J, Cosset FL. 2014. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol 61:S3-S13. http://dx.doi.org/10.1016/j.jhep.2014.06.031.
16. Phillips MC. 2014. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life 66:616-623. http://dx.doi.org/10.1002/iub.1314.
17. Shimizu Y, Hishiki T, Ujino S, Sugiyama K, Funami K, Shimotohno K. 2011. Lipoprotein component associated with hepatitis C virus is essential for virus infectivity. Curr Opin Virol 1:19-26. http://dx.doi.org/10.1016/j.coviro.2011.05.017.
18. Sundaram M, Yao Z. 2012. Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion. Arterioscler Thromb Vasc Biol 32:1073-1078. http://dx.doi.org/10.1161/ATVBAHA.111.241455.
19. Albecka A, Belouzard S, Op de Beeck A, Descamps V, Goueslain L, Bertrand-Michel J, Terce F, Duverlie G, Rouille Y, Dubuisson J. 2012. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 55:998-1007. http://dx.doi.org/10.1002/hep.25501.
20. Chang KS, Jiang J, Cai Z, Luo G. 2007. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81:13783-13793. http://dx.doi.org/10.1128/JVI.01091-07.
21. Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G. 2012. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 86:7256-7267. http://dx.doi.org/10.1128/JVI.07222-11.
22. Jiang J, Wu X, Tang H, Luo G. 2013. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors. PLoS One 8:e67982. http://dx.doi.org/10.1371/journal.pone.0067982.
23. Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T. 2012. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Hepatology 56:484-491. http://dx.doi.org/10.1002/hep.25665.
24. Long G, Hiet MS, Windisch MP, Lee JY, Lohmann V, Bartenschlager R. 2011. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 141:1057-1066. http://dx.doi.org/10.1053/j.gastro.2011.06.010.
25. Owen DM, Huang H, Ye J, Gale M, Jr. 2009. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with lowdensity lipoprotein receptor. Virology 394:99-108. http://dx.doi.org/10.1016/j.virol.2009.08.037.
26. Huang Y, Mahley RW. 2014. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis 72(Part A):3-12.
27. Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S. 2009. Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry 48:3025-3032. http://dx.doi.org/10.1021/bi9000694.
28. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. http://dx.doi.org/10.1126/science.1114016.
29. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796. http://dx.doi.org/10.1038/nm1268.
30. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102:9294-9299. http://dx.doi.org/10.1073/pnas.0503596102.
31. Gillard BK, Lin HY, Massey JB, Pownall HJ. 2009. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochim Biophys Acta 1791: 1125-1132. http://dx.doi.org/10.1016/j.bbalip.2009.07.004.
32. Merz A, Long G, Hiet MS, Brugger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. 2011. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 286:3018-3032. http://dx.doi.org/10.1074/jbc.M110.175018.
33. Martin C, Nielsen SU, Ibrahim S, Bassendine MF, Toms GL. 2008. Binding of liver derived, low density hepatitis C virus to human hepatoma cells. J Med Virol 80:816-823. http://dx.doi.org/10.1002/jmv.21150.
34. Dao Thi VL, Granier C, Zeisel MB, Guerin M, Mancip J, Granio O, Penin F, Lavillette D, Bartenschlager R, Baumert TF, Cosset FL, Dreux M. 2012. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J Biol Chem 287:31242-31257. http://dx.doi.org/10.1074/jbc.M112.365924.
35. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. 2008. Cellular determinants of hepatitis C virus assembly, maturation, degrada-tion, and secretion. J Virol 82:2120-2129. http://dx.doi.org/10.1128/JVI.02053-07.
36. Jiang J, Luo G. 2009. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol 83:12680-12691. http://dx.doi.org/10.1128/JVI.01476-09.
37. Lin CC, Tsai P, Sun HY, Hsu MC, Lee JC, Wu IC, Tsao CW, Chang TT, Young KC. 2014. Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production. J Hepatol 61:984-993. http://dx.doi.org/10.1016/j.jhep.2014.06.026.
38. Lee JY, Acosta EG, Stoeck IK, Long G, Hiet MS, Mueller B, Fackler OT, Kallis S, Bartenschlager R. 2014. Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J Virol 88:12422-12437. http://dx.doi.org/10.1128/JVI.01660-14.
39. Mazumdar B, Banerjee A, Meyer K, Ray R. 2011. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology 54:1149-1156. http://dx.doi.org/10.1002/hep.24523.
40. Fukuhara T, Wada M, Nakamura S, Ono C, Shiokawa M, Yamamoto S, Motomura T, Okamoto T, Okuzaki D, Yamamoto M, Saito I, Wakita T, Koike K, Matsuura Y. 2014. Amphipathic alpha-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles. PLoS Pathog 10:e1004534. http://dx.doi.org/10.1371/journal.ppat.1004534.
41. Cun W, Jiang J, Luo G. 2010. The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. J Virol 84:11532-11541. http://dx.doi.org/10.1128/JVI.01021-10.
42. Fauvelle C, Felmlee DJ, Crouchet E, Lee J, Heydmann L, Lefevre M, Magri A, Hiet MS, Fofana I, Habersetzer F, Foung SK, Milne R, Patel AH, Vercauteren K, Meuleman P, Zeisel MB, Bartenschlager R, Schuster C, Baumert TF. 2016. Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies. Gastroenterology 150:206-217 e4. http://dx.doi.org/10.1053/j.gastro.2015.09.014.
43. Younossi ZM, Elsheikh E, Stepanova M, Gerber L, Nader F, Stamm LM, Brainard DM, McHutchinson JG. 2015. Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels. J Viral Hepat 22:977-982. http://dx.doi.org/10.1111/jvh.12448.
44. Bartosch B, Vermey G, Dreux M, Donot P, Morice Y, Penin F, Pawlotsky JM, Lavillette D, Cosset FL. 2005. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79:8217-8229. http://dx.doi.org/10.1128/JVI.79.13.8217-8229.2005.